These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 897837)

  • 61. Hormonal responses to intravenous glucose and arginine in patients with pancreatitis.
    Duckworth WC; Solomon SS; Jallepalli P; Iyer R; Bobal MA
    Horm Res; 1983; 17(2):65-73. PubMed ID: 6341194
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of somatostatin on insulin and glucagon in patients with insulinoma.
    Fallucca F; Mirabella C; Tamburrano G; Gambardella S; Aufieri G; Barbetti F; Andreani D
    J Endocrinol Invest; 1979; 2(3):257-60. PubMed ID: 231062
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phentolamine and the action of somatostatin in man.
    Schmitt JK; Lorenzi M; Gerich JE; Bohannon NV; Karam JH; Forsham PH
    J Clin Endocrinol Metab; 1979 May; 48(5):880-2. PubMed ID: 219013
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Antisomatostatin serum increases levels of hormones from the pituitary and gut, but not from the pancreas.
    Schusdziarra V; Rouiller D; Arimura A; Unger RH
    Endocrinology; 1978 Nov; 103(5):1956-9. PubMed ID: 748027
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acute hormonal effects on carnitine metabolism in thin and obese subjects: responses to somatostatin, glucagon, and insulin.
    Genuth SM; Hoppel CL
    Metabolism; 1981 Apr; 30(4):393-401. PubMed ID: 6111018
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effects of hexoprenaline, a beta 2-sympathomimetic drug, on maternal glucose, insulin, glucagon, and free fatty acid levels.
    Lipshitz J; Vinik AI
    Am J Obstet Gynecol; 1978 Apr; 130(7):761-4. PubMed ID: 637098
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hormonal responses to cardiac surgery: effects of sufentanil, somatostatin and ganglion block.
    Desborough JP; Hall GM; Hart GR; Burrin JM; Bloom SR
    Br J Anaesth; 1990 Jun; 64(6):688-95. PubMed ID: 1974142
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of prosomatostatin on growth hormone and prolactin response to arginine in man. Comparison with somatostatin.
    Rodriguez-Arnao MD; Gomez-Pan A; Rainbow SJ; Woodhead S; Comaru-Schally AM; Schally AV; Meyers CA; Coy DH; Hall R
    Lancet; 1981 Feb; 1(8216):353-6. PubMed ID: 6109991
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly.
    Charro AL; Cabranes JA; Lafuente A; Diaz-Salgado C; Cordero M; Almoguera I; Comaru-Schally AM; Meyers CA; Coy DH; Schally AV
    Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):432-44. PubMed ID: 6150529
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics.
    Gerich JE; Lorenzi M; Schneider V; Kwan CW; Karam JH; Guillemin R; Forsham PH
    Diabetes; 1974 Nov; 23(11):876-80. PubMed ID: 4430415
    [No Abstract]   [Full Text] [Related]  

  • 71. The effect of somatostatin on plasma insulin and growth hormone levels in basal conditions and after glucagon in normal and acromegalic subjects.
    Massara F; Porzio G; Camanni F; Molinatti GM
    Acta Diabetol Lat; 1975; 12(3-4):219-31. PubMed ID: 1224905
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of intestinal glucagon-like immunoreactivity (GLI) secretion by somatostatin in man.
    Marco J; Hedo JA; Villaneuva ML
    J Clin Endocrinol Metab; 1977 Apr; 44(4):695-8. PubMed ID: 849979
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analog.
    Lien EL; Fenichel RL; Grant NH; Boxill GC; Greenwood J; Yardley JP
    Biochem Biophys Res Commun; 1977 Aug; 77(4):1317-25. PubMed ID: 143285
    [No Abstract]   [Full Text] [Related]  

  • 74. Effect of somatostatin on insulin-induced hypoglycemia in man.
    Adamson U; Efendic S; Lins PE; Wajngot A
    Acta Med Scand; 1982; 212(1-2):33-7. PubMed ID: 6126999
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relationship between pancreatic hormones and glucose metabolism: A cross-sectional study in patients after acute pancreatitis.
    Pendharkar SA; Asrani VM; Xiao AY; Yoon HD; Murphy R; Windsor JA; Petrov MS
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G50-8. PubMed ID: 27173509
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diabetes mellitus secondary to idiopathic chronic calcifying pancreatitis in an adolescent woman.
    Kazumi T; Ohya M; Suehiro I; Mizuno N; Morita S; Oimomi M; Baba S
    Endocrinol Jpn; 1983 Apr; 30(2):261-6. PubMed ID: 6357771
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Studies on the mechanism of somatostatin action on insulin release in man. II. Comparison of the effects of somatostatin on insulin release induced by glucose, glucagon and tolbutamide.
    Efendić S; Luft R; Claro A
    Acta Endocrinol (Copenh); 1976 Apr; 81(4):743-52. PubMed ID: 946564
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hormonal and metabolic responses to intravenous glucose in children on regular hemodialysis.
    El-Bishti MM; Counahan R; Bloom SR; Chantler C
    Am J Clin Nutr; 1978 Oct; 31(10):1865-9. PubMed ID: 707340
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effect of somatostatin on the response of GLI to the intraduodenal administration of glucose, protein, and fat.
    Sakurai H; Dobbs RE; Unger RH
    Diabetologia; 1975 Oct; 11(5):427-30. PubMed ID: 1181667
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of glucose-induced insulin secretion by somatostatin in goats.
    Maglad MA; Wasfi IA; Adam SE
    Res Vet Sci; 1983 Jul; 35(1):19-21. PubMed ID: 6137867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.